Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Epista Life Science is remediating data across 800+ studies and 4 million documents for a global pharma company to boost accuracy, compliance, and digital readiness.
Epista Life Science has launched a major clinical data remediation effort with a global pharmaceutical company, addressing over 800 studies and 4 million documents to improve data accuracy, compliance, and readiness for digital systems.
The multi-phase program, the largest of its kind for Epista, aims to enhance trial management, support a next-generation CTMS, and strengthen data governance.
It leverages Epista’s methodology and the DNANexus platform to standardize data, ensure real-time regulatory oversight, and prepare for advanced analytics and AI.
The initiative is designed to reduce inspection risks, speed up study startup, and build a trusted, future-ready data foundation, marking a significant step in the industry’s push for higher data quality and transparency.
Epista Life Science está remediando los datos de más de 800 estudios y 4 millones de documentos para una compañía farmacéutica global para aumentar la precisión, el cumplimiento y la preparación digital.